Yearly Publication Trends - generic drugs

Year	Publication Count
2024	283
2023	617
2022	383
2021	310
2020	250
2019	246
2018	183
2017	175
2016	114
2015	86
2014	95

Relevant Publications

PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) - a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative study.

Issue Release: 2024

A conceptual framework to build effective medicine pricing policies for low and middle-income countries (LMICs).

Issue Release: 2024

Prediction and Interpretation Microglia Cytotoxicity by Machine Learning.

Issue Release: 2024

Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response.

Issue Release: 2024

Patient-Level Savings on Generic Drugs Through the Mark Cuban Cost Plus Drug Company.

Issue Release: 2024

International Prescription Drug Price Comparisons: Estimates Using 2022 Data.

Issue Release: 2024

Cutaneous Pharmacokinetics-Based Bioequivalence: A Clinical Dermal Open Flow Microperfusion Verification Study Using Lidocaine and Prilocaine Combination Topical Products.

Issue Release: 2024

Tailoring drug release from long-acting contraceptive levonorgestrel intrauterine systems.

Issue Release: 2024

Prescription-based cost analysis of medicines for cardiovascular risk factors at Indian Council of Medical Research-Rational Use of Medicine Centre Hospitals of India.

Issue Release: 2024

Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing.

Issue Release: 2024

Comparative Bleeding Risk of Brand Vs Generic Rivaroxaban in Elderly Inpatients with Atrial Fibrillation.

Issue Release: 2024

Spending on nucleos(t)ide analogues for hepatitis B in medicaid beneficiaries: 2012-2021.

Issue Release: 2024

Comparative evaluation of dissolution profiles of the generic drug lamivudine 150 mg tablet marketed in Peru vs. the innovative Epivir.

Issue Release: 2024

Physiologically based absorption modeling to predict the bioequivalence of two apixaban formulations.

Issue Release: 2024

Impact of Incorporating Future Mandatory Price Reductions with Generic Drug Entry on the Cost-Effectiveness of New Drugs: A Policy Simulation Study of Dupilumab in Atopic Dermatitis Treatment.

Issue Release: 2024

Bioequivalence Study of Two Formulations of Simvastatin 20 mg Tablet in Healthy Filipino Participants under Fasting Conditions: A Randomized, Open-label, Two-way Crossover Study.

Issue Release: 2024

Influencing Factors of Generic Prescribing Behavior of Physicians: A Structural Equation Model Based on the Theory of Planned Behavior.

Issue Release: 2024

The politics and governance of drug production in public-private partnerships: Brazils response to hepatitis C.

Issue Release: 2024

Assessment of disease pattern and drug utilization among neurology intensive care unit patients in a developing country: an observational analysis.

Issue Release: 2024

Generic cancer drugs are still in short supply: The ongoing shortage has forced hospitals to continue rationing drugs and prompted new calls for federal investment and long-term solutions.

Issue Release: 2024

What are the Key Challenges?

What Challenges Exist in Patient Education?

How Can Pharma Companies Improve Patient Education?

Who are Pharmacists?

What is Pharmaceutical Science?

How Long Does the Approval Process Take?

Why is Patient Education Important?

Why is the Management of Chronic Conditions Important?

What is Regulatory Approval?

What Are the Challenges of Clinical Trials?

Yearly Publication Trends - generic drugs

Relevant Publications

Relevant Topics

Partnered Content Networks

Relevant Topics